{
    "clinical_study": {
        "@rank": "43793", 
        "brief_summary": {
            "textblock": "The goal of this study is to aggressively treat insulin resistance and its clinical\n      manifestations when they first appear in childhood, and to prevent the subsequent\n      progression towards impaired glucose tolerance and type-2 diabetes.  In the process of this\n      clinical trial, we will learn more about the early manifestations of insulin resistance, its\n      treatment, and its relationship to obesity and type-2 diabetes through parallel in-vivo and\n      in-vitro studies."
        }, 
        "brief_title": "A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)", 
        "condition": [
            "Insulin Resistance", 
            "Diabetes Mellitus"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2", 
                "Insulin Resistance"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          1. Obese patients (wt > 95th percentile for age, for adults increased BMI > 27) greater\n             than 5 years of age\n\n          2. And/or presence of complications of insulin resistance such as acanthosis nigricans,\n             dyslipidemia, elevated blood pressure, hyperandrogenism\n\n          3. Siblings and parents of patients with insulin resistance.  Siblings and parents will\n             be included only in the case of documented insulin resistance in the index subject.\n             Insulin resistance will be documented by OGTT and/or IVGTT.\n\n          4. Family history of type II diabetes.\n\n        Exclusion Criteria:\n\n          1. Critically ill patients, patients will congestive heart failure, renal or liver\n             insufficiency\n\n          2. Inability to give consent.\n\n          3. History of poor compliance with physician's recommendations"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "5 Years"
        }, 
        "enrollment": "300", 
        "firstreceived_date": "April 24, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00015626", 
            "org_study_id": "NCRR-M01RR06020-0057"
        }, 
        "intervention": [
            {
                "intervention_name": "Metformin", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "skin biopsy", 
                "intervention_type": "Procedure"
            }, 
            {
                "intervention_name": "diet and exercise", 
                "intervention_type": "Behavioral"
            }, 
            {
                "intervention_name": "pioglitazone", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "rosiglitazone", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Pioglitazone", 
                "Rosiglitazone", 
                "Metformin"
            ]
        }, 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10021"
                }, 
                "name": "Cornell University"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00015626"
        }, 
        "source": "National Center for Research Resources (NCRR)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2003"
    }, 
    "geocoordinates": {
        "Cornell University": "40.714 -74.006"
    }
}